PCDH19 and Dravet syndrome: This neurosteroid, being a positive allosteric modulator of GABAA receptors, is also used in the treatment of epilepsy related to PCDH19 clusters, status epilepticus accompanying Dravet syndrome, and infant convulsions following hypoxic brain damage.